Article
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product
2024-03-14
Abstract excerpt
Circulating Tumor Cells (CTCs), interrogated by sampling blood from patients with cancer, contain multiple analytes, including intact RNA, high molecular weight DNA, proteins, and metabolic markers. However, the clinical utility of tumor cell-based liquid biopsy has been limited since CTCs are very rare, and current technologies cannot process the blood volumes required to isolate a sufficient number of tumor cell...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 20448088-7e34-53c8-a35c-da4975ddbddc
- DOI
- 10.1101/2024.03.13.583573
